Biomaterials-directed regenerative immunotherapies
Biomaterials-directed regenerative immunotherapies
批准号:
10697362
负责人:
JENNIFER H ELISSEEFF
金额:
$114.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-25 至 2024-08-31
关键词:
Adaptive Immune SystemAgingBiocompatible MaterialsBiologicalBlood VesselsCellsCicatrixClinicClinicalComputational algorithmCongenital AbnormalityCuesDevelopmentDiseaseEngineeringFoundationsGenomicsHomeostasisHumanImmuneImmune responseImmune systemImmunityImmunotherapyInterventionMediatingMolecularMorphogenesisMusculoskeletalNatural regenerationPathway interactionsRegenerative MedicineRoleSystemT-LymphocyteTherapeuticThinkingTissue EngineeringTissuesTraumabioscaffoldcancer immunotherapydesignengineering designfirst responderhealingimprovedinnovationnovelregeneration potentialregenerativerepairedresponsesenescencestandard of carestem cellssuccesstherapy designtissue repairtissue traumatissue-repair responsestool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Tissue loss due to trauma, disease or congenital abnormalities remains an intractable clinical
challenge. There are profound deficits in how humans heal and recover from tissue damage and few
innovations in regenerative medicine have reached the clinic or improved standard of care. Formation of
dysfunctional scar tissue remains the default pathway for repair in the body. The immune system is the first
responder to trauma yet this response, and its capacity to orchestrate tissue repair, has been largely ignored.
Engineering tissues generally involves combining cells and biomaterial scaffolds with a suite of biological cues
to stimulate new tissue development. Until now, these tissue engineering tools have been designed to target
stem cells, vascular development, or tissue morphogenesis. Here, we are shifting the focus of tissue
engineering design towards direct therapeutic manipulation of the immune system. The remarkable success of
cancer immunotherapies highlights how the adaptive immune system is amenable to exquisitely robust
intervention and the potential for regenerative immunotherapies. We introduce the concept of regenerative
immunotherapies that engage and manipulate the effector class of T cells. Emerging understanding of tissue
specific immunity, the role of senescent cells in tissue trauma and repair responses will be combined with our
new and unexpected findings on pro-regenerative T cells. Single cell genomic analysis of immune subsets,
stromal, and senescent cells combined with novel computational algorithms will be used to develop tissue-
specific senescent and immune networks in homeostasis, aging, trauma, and disease. This foundation will
serve as the basis for cell and molecular therapy design to enhance T cell mediated pro-regenerative immune
responses. While broadly applicable to many tissues, we will first apply regenerative immunotherapies to
musculoskeletal tissues before extending to additional tissues. Collectively, these studies will transform
traditional thinking of the immune system by re-imagining the immune system as the body’s repair system and
use this platform to engineer regeneration.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1089/ten.teb.2019.0335
发表时间:
2020-07
期刊:
Tissue engineering. Part B, Reviews
影响因子:
--
作者:
[E. Moore;David R Maestas;Hannah Y. Comeau;J. Elisseeff]
通讯作者:
E. Moore;David R Maestas;Hannah Y. Comeau;J. Elisseeff
Administrative Core
-
批准号:10556889
-
项目类别:
-
资助金额:$8.84万
-
财政年份:2022
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Administrative Core
-
批准号:10673113
-
项目类别:
-
资助金额:$9.16万
-
财政年份:2022
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Single cell characterization of the biomaterial immune and stromal response
-
批准号:10230987
-
项目类别:
-
资助金额:$60.66万
-
财政年份:2020
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Single cell characterization of the biomaterial immune and stromal response
-
批准号:10431933
-
项目类别:
-
资助金额:$61.23万
-
财政年份:2020
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Single cell characterization of the biomaterial immune and stromal response
-
批准号:10617307
-
项目类别:
-
资助金额:$61.23万
-
财政年份:2020
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Biomaterials-directed regenerative immunotherapies
-
批准号:10023168
-
项目类别:
-
资助金额:$114.63万
-
财政年份:2019
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
-
批准号:10375406
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2019
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Biomaterials-directed regenerative immunotherapies
-
批准号:10251325
-
项目类别:
-
资助金额:$114.63万
-
财政年份:2019
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
-
批准号:10599230
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2019
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Statistical optimization of self-assembled biosynthetic cornea implants
-
批准号:9913555
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2018
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Statistical optimization of self-assembled biosynthetic cornea implants
-
批准号:10159911
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2018
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Glucosamine and Novel Anolgs for Cartilage Regeneration
-
批准号:8134947
-
项目类别:
-
资助金额:$40.73万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Tissue Engineering in Congenital Craniofacial Defects
-
批准号:7094750
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Tissue Engineering in Congenital Craniofacial Defects
-
批准号:7245069
-
项目类别:
-
资助金额:$32.77万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Synthesis amd Mechanism of Polyglucosamine for Cartilage Tissue Engineering
-
批准号:7257076
-
项目类别:
-
资助金额:$26.9万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Synthesis amd Mechanism of Polyglucosamine for Cartilage Tissue Engineering
-
批准号:7437315
-
项目类别:
-
资助金额:$27.16万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Glucosamine and Novel Anolgs for Cartilage Regeneration
-
批准号:8484741
-
项目类别:
-
资助金额:$44.67万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Tissue Engineering in Congenital Craniofacial Defects
-
批准号:7636218
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Glucosamine and Novel Anolgs for Cartilage Regeneration
-
批准号:8065308
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
Glucosamine and Novel Anolgs for Cartilage Regeneration
-
批准号:8271304
-
项目类别:
-
资助金额:$40.73万
-
财政年份:2006
-
负责人:JENNIFER H ELISSEEFF
-
依托单位:
海外基金